-

Vizient Announces Strategic Partnership with My Green Lab to Lower Environmental Impact in Clinical Laboratories

IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announces a strategic partnership with My Green Lab, a global nonprofit organization dedicated to laboratory sustainability, to lower the environmental impact of laboratory supplies in the clinical lab space. The agreement was announced at My Green Lab’s annual summit today.

“Vizient has been working to create industry alignment between suppliers of products used in medical laboratories and in our member hospitals, and this is the next step in that journey,” said Mellissa Nguyen, senior program services manager, Environmentally Preferred Sourcing, Vizient. “This collaboration will accelerate the work necessary to enable Vizient members to easily identify laboratory supplies within the Vizient portfolio that are environmentally friendly, thus offering a new level of protection for laboratorians in those environments.”

In 2018, My Green Lab launched the first eco-label for laboratory products, ACT, which stands for Accountability Consistency and Transparency. Since then, the program has grown to nearly 500 products from 10 leading manufacturers and is scaling rapidly.

“Partnering with Vizient to bring My Green Lab’s approach to the clinical lab supplies market will align sustainable product demand in research and clinical labs. By speaking to the market in a common voice we can accelerate the transformation of both health care and scientific supply chains,” said James Connelly, My Green Lab’s chief executive officer.

Through the partnership, Vizient will begin developing standards, based on input from its suppliers and member hospitals, for its clinical lab portfolio of products. The company expects to begin using these standards in its bid process for vendors and distributors by the end of 2021, bringing about a safer, healthier and more sustainable environment for lab clinicians and patients.

My Green Lab, which has led the global effort of safety standards in research laboratories, is a nonprofit organization dedicated to improving the sustainability of scientific research to reflect the highest standards of social and environmental responsibility.

Vizient launched its Environmentally Preferred Sourcing program in 2017 to help health care providers easily access a wide array of products that are safe for patients and caregivers while minimizing environmental impact.

About Vizient, Inc.

Vizient, Inc. provides solutions and services that improve the delivery of high-value care by aligning cost, quality and market performance for more than 50% of the nation’s acute care providers, which includes 95% of the nation’s academic medical centers, and more than 20% of ambulatory care providers. Vizient provides expertise, analytics and advisory services, as well as a contract portfolio that represents more than $100 billion in annual purchasing volume, to improve patient outcomes and lower costs. Vizient has earned a World’s Most Ethical Company designation from the Ethisphere Institute every year since its inception. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at www.vizientinc.com.

Contacts

Donna Ledbetter
(972) 830-6321
donna.ledbetter@vizientinc.com

Vizient, Inc.


Release Summary
Vizient announces a strategic partnership with My Green Lab, a global nonprofit organization dedicated to laboratory sustainability.
Release Versions

Contacts

Donna Ledbetter
(972) 830-6321
donna.ledbetter@vizientinc.com

Social Media Profiles
More News From Vizient, Inc.

Byron Jobe Recognized as One of Modern Healthcare’s 100 Most Influential People in Healthcare

IRVING, Texas--(BUSINESS WIRE)--This recognition acknowledges individuals who are deemed to be the most influential figures in the industry in terms of leadership and impact....

New Data Show Hospitals Continue to Improve Performance on Key Patient Safety Measures and Outcomes in 2025

WASHINGTON & IRVING, Texas--(BUSINESS WIRE)--Patient safety throughout health systems across the nation continue to improve, according to the American Hospital Association (AHA) and Vizient®....

Vizient Applauds FDA’s Recent Actions to Accelerate Biosimilar Development and Lower Costs

IRVING, Texas--(BUSINESS WIRE)--Vizient® commends the FDA for announcing actions to accelerate biosimilar development, including greater clarity for comparative efficacy studies....
Back to Newsroom